We are live on ! Find out more
MBOT icon

Microbot Medical

26 hedge funds and large institutions have $5.52M invested in Microbot Medical in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

7% more capital invested

Capital invested by funds: $5.16M → $5.52M (+$359K)

7% less funds holding

Funds holding: 2826 (-2)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
2
Closed
6
Calls
Puts
Net Calls
Net Calls Change

MBOT Hedge Fund Activity: Q3 2013 in Review

26 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2013, worth a combined $5.52M — up 7% from $5.16M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of MBOT and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 8 added.

The largest buyer was BlackRock Institutional Trust, adding an estimated $228K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $55K sold.

  • 26 institutional investors held Microbot Medical (MBOT) as of Q3 2013, down from 28 in Q2 2013.
  • Funds reported $5.52M of Microbot Medical stock for Q3 2013, up 7% quarter-over-quarter.
  • 5 funds opened new Microbot Medical positions in Q3 2013 and 6 closed out, a net change of -1 holder.
  • The largest Microbot Medical buyer in Q3 2013 was BlackRock Institutional Trust, an estimated $228K added.
  • The largest Microbot Medical seller in Q3 2013 was A.R.T. Advisors, an estimated $55K sold.

Based on aggregated 13F filings for Q3 2013.